Vulnerabilities for Drug Diversion in the Handling, Data Entry, and Verification Tasks of 2 Inpatient Hospital Pharmacies: Clinical Observations and Healthcare Failure Mode and Effect Analysis
- PMID: 32740137
- PMCID: PMC8719512
- DOI: 10.1097/PTS.0000000000000744
Vulnerabilities for Drug Diversion in the Handling, Data Entry, and Verification Tasks of 2 Inpatient Hospital Pharmacies: Clinical Observations and Healthcare Failure Mode and Effect Analysis
Abstract
Objectives: Inpatient hospital pharmacies have a central role in managing controlled substances (CS) throughout the hospital medication use process (MUP). Our objectives were to identify vulnerabilities for diversion in the MUPs of 2 inpatient pharmacies, explore differences between the sites, and characterize the types of vulnerabilities identified.
Methods: We conducted clinical observations in 2 pharmacies to map their MUPs and performed a healthcare failure mode and effect analysis to proactively identify (1) the critical failure modes (CFMs) that make them vulnerable to diversion and (2) the controls that prevent, mitigate, or enhance the detectability of CFMs.
Results: We conducted 99 hours of observations between May-June and September-October 2018. We observed 36 pharmacy technicians, 4 pharmacists, and 1 clerk as they conducted tasks involving 4 processes common to both sites: procuring CS, receiving CS deliveries to the pharmacy, unit-dose packaging CS oral solids, and distributing CS to hospital units. The tasks and subtasks we mapped in the process flow diagrams led to the identification of 220 failure modes. Of these, 34 were deemed CFMs and were categorized as related to handling CS, data entry, or verification tasks. Three of the CFMs were unique to one site, given that the other site had a control for the CFM.
Conclusions: Multiple vulnerabilities for diversion exist in inpatient pharmacy processes. Our results provide some much needed detail about how specific vulnerabilities in MUP tasks and subtasks lead to an increased risk of diversion.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.
Figures
References
-
- Access to information and privacy division - Health Canada . Reports of controlled drug (including narcotics) diversion/loss/misuse in Canada (including but not limited to those reported to the Office of Controlled Substances) from the period of Jan 1, 2016 to Dec 31, 2016. Information file: A-2017-000435 2017.
-
- Fan M Tscheng D Hamilton M, et al. . Diversion of controlled drugs in hospitals: a scoping review of contributors and safeguards. J Hosp Med. 2019;14:419–428. - PubMed
-
- Canadian Society of Hospital Pharmacists . Controlled drugs and substances in hospitals and healthcare facilities: guidelines on secure management and diversion prevention. Ottawa, ON; 2019:52. https://www.cshp.ca/cshps-controlled-drugs-and-substances-hospitals-and-.... Accessed March 21, 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
